Atherotech Names Leading Cholesterol Expert Paul Ziajka as Chief Medical Officer.BIRMINGHAM, Ala. -- Atherotech, Inc., a pioneer in cardiodiagnostic technology, today announced that it has appointed Paul Ziajka, M.D., Ph.D., as chief medical officer. In his new role, Ziajka, one of the nation's foremost experts in the field of lipid (or cholesterol) management, will work to educate healthcare professionals about Atherotech's VAP (Value Added Process) An executable program in a NetWare 2.x server. Starting with NetWare 3.x, VAPs were replaced by NLMs. See NetWare. (TM) Cholesterol Test Cholesterol Test Definition The cholesterol test is a quantitative analysis of the cholesterol levels in a sample of the patient's blood. Total serum cholesterol (TC) is the measurement routinely taken. and will interface with the company's key constituencies. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Roseanne Varner, Atherotech's president and chief executive officer, the appointment of Ziajka is a major achievement for the company and its VAP (Vertical Auto Profile) Cholesterol Test. "Paul Ziajka is a leading expert in cholesterol management and the use of expanded lipid testing for the diagnosis and treatment of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. ," Varner said. "His nationally recognized leadership and leading-edge knowledge of cholesterol management will be an invaluable addition as we continue to expand the adoption of the test among physicians, diagnostic labs, and our pharmaceutical partners." Ziajka is the founder and director of the Florida Lipid Institute and is a clinical assistant professor in the Department of Medicine at the University of Florida University of Florida is the third-largest university in the United States, with 50,912 students (as of Fall 2006) and has the eighth-largest budget (nearly $1.9 billion per year). UF is home to 16 colleges and more than 150 research centers and institutes. at Gainesville and the Department of Clinical Sciences at Florida State University School Florida State University School, or "Florida High", is located within the Southwood community in the southeast part of Tallahassee, Florida, USA. A charter school that serves kindergarten and grades one through twelve, Florida High is sponsored by Florida State University's of Medicine. He is a renowned researcher and speaker on the diagnosis and treatment of lipid disorders and the use of lipid subfractionation, making presentations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. for pharmaceutical leaders, including Astra Zeneca, Merck, and Schering-Plough. Ziajka also is a member of the American Heart Association's Atherosclerosis atherosclerosis (ăth'ərōsklərō`sĭs): see arteriosclerosis. atherosclerosis or hardening of the arteries Scientific Council. "I am very pleased to be joining Atherotech," Ziajka said. "I am impressed with the company's solid management team and its commitment to the early detection and prevention of heart disease, along with the VAP Test technology. Use of the VAP Test is essential and will become increasingly more common for two reasons. First, the expanded information it provides helps physicians better identify at-risk patients. Second, that detailed information aids physicians in the development of customized, effective treatment plans." About the VAP Cholesterol Test The VAP Test measures the basic information provided by routine cholesterol tests, plus a range of cholesterol "subclasses" that play significant roles in the development of heart disease. The VAP Test identifies more than 90 percent of people at risk, compared with just 40 percent with the routine panel, and it complies with National Cholesterol Education Program The National Cholesterol Education Program is a program managed by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. Its goal is to reduce increased cardiovascular disease rates due to hypercholesterolemia (elevated cholesterol guidelines, which focus attention on emerging risk factors and secondary targets of therapy for heart disease. The VAP Test is available nationwide through national and regional diagnostic laboratories and is reimbursed by most payors, including Medicare. Samples are processed in Atherotech's state-of-the-art laboratory in Birmingham. About Atherotech Atherotech is dedicated to improving the early diagnosis and treatment of heart disease and other cardiovascular diseases that kill nearly 1 million Americans each year. Atherotech's VAP Test, the new standard of care in cholesterol risk assessment, was named one of "five tests worth paying for" by The Wall Street Journal. In addition, Forbes.com selected the VAP Test as one of "ten ways to live longer." For more information, visit www.thevaptest.com. Note to editors: For additional information or a photo of Dr. Ziajka, please call Barbara Sullivan Barbara Sullivan (born January 24, 1943 in Calgary, Alberta) is a former politician in Ontario, Canada. She was a Liberal member of the Legislative Assembly of Ontario from 1987 to 1995. Sullivan was educated at the Carleton University School of Journalism. at 714-374-6174. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion